These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 2677169

  • 1. [Immunohistochemical study on the MHC class I antigen expression on squamous cell carcinoma of the uterine cervix].
    Honma S, Nakamura M, Maruhashi T, Kodama S, Obata N, Kanazawa K, Takahashi T, Sasagawa S, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):813-8. PubMed ID: 2677169
    [Abstract] [Full Text] [Related]

  • 2. [Immunohistological study on HLA class II antigen expression and lymphocyte infiltration in cancer tissues of the uterine cervix].
    Nakamura M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):349-56. PubMed ID: 1607758
    [Abstract] [Full Text] [Related]

  • 3. [An immunohistochemical study on regional immunological response of uterine cervical cancer].
    Okamoto Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):456-62. PubMed ID: 2373918
    [Abstract] [Full Text] [Related]

  • 4. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS, Duggan-Keen M, Cabrera T, Stern PL.
    Cancer Res; 1992 Jul 15; 52(14):4009-16. PubMed ID: 1377602
    [Abstract] [Full Text] [Related]

  • 5. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
    Andratschke M, Pauli C, Stein M, Chaubal S, Wollenberg B.
    Anticancer Res; 2003 Jul 15; 23(2B):1467-71. PubMed ID: 12820411
    [Abstract] [Full Text] [Related]

  • 6. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
    Lazaris ACh, Chatzigianni EB, Xidias G, Panoskaltsis TA, Thomopoulou GC, Eftychiadis CA, Michalas S, Patsouris ES.
    J Exp Clin Cancer Res; 2004 Jun 15; 23(2):269-75. PubMed ID: 15354412
    [Abstract] [Full Text] [Related]

  • 7. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG, Munoz IM, Nooyen Y, Fleuren GJ.
    Gynecol Oncol; 1995 Jun 15; 57(3):366-75. PubMed ID: 7774840
    [Abstract] [Full Text] [Related]

  • 8. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression.
    Cromme FV, Snijders PJ, van den Brule AJ, Kenemans P, Meijer CJ, Walboomers JM.
    Oncogene; 1993 Nov 15; 8(11):2969-75. PubMed ID: 8414499
    [Abstract] [Full Text] [Related]

  • 9. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
    Kloth JN, Gorter A, Fleuren GJ, Oosting J, Uljee S, ter Haar N, Dreef EJ, Kenter GG, Jordanova ES.
    J Pathol; 2008 Jul 15; 215(3):222-30. PubMed ID: 18438953
    [Abstract] [Full Text] [Related]

  • 10. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
    Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA.
    Clin Cancer Res; 2000 Jul 15; 6(7):2794-802. PubMed ID: 10914726
    [Abstract] [Full Text] [Related]

  • 11. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
    Okamoto Y, Ueda M, Yamada T, Misaki O, Seiki Y, Tsurunaga T, Iwai E, Ueki M, Sugimoto O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec 15; 40(12):1819-25. PubMed ID: 2974857
    [Abstract] [Full Text] [Related]

  • 12. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG, van der Burg SH, Fleuren GJ.
    Clin Cancer Res; 2008 Apr 01; 14(7):2028-35. PubMed ID: 18381941
    [Abstract] [Full Text] [Related]

  • 13. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
    Ryu KS, Lee YS, Kim BK, Park YG, Kim YW, Hur SY, Kim TE, Kim IK, Kim JW.
    Exp Mol Med; 2001 Sep 30; 33(3):136-44. PubMed ID: 11642549
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
    Yamasaki M, Ueda G, Inoue M, Tanaka Y, Tanizawa O, Kurachi K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan 30; 33(1):151-4. PubMed ID: 7014735
    [Abstract] [Full Text] [Related]

  • 16. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].
    Niu C, Liu X, Zhou W, Jing L, Du B.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun 30; 37(3):215-8. PubMed ID: 12772327
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER.
    Cancer Res; 1999 Sep 15; 59(18):4642-50. PubMed ID: 10493519
    [Abstract] [Full Text] [Related]

  • 19. Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma.
    van Driel WJ, Tjiong MY, Hilders CG, Trimbos BJ, Fleuren GJ.
    Gynecol Oncol; 1996 Jul 15; 62(1):33-41. PubMed ID: 8690288
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.